Dr. Daniel Vitt

Dr. Daniel Vitt

Chief Executive OfficeratImmunic· In proxies 2023–2024

Pay in FY2024+142% from the year before · Immunic stock -33.3% the same year

Dr. Daniel Vitt was paid $2.9M in FY2024 (Dec), up 142%. Immunic stock fell 33.3% that year.

Pay$100 in the stock at the end of FY22 → $71
Pay is from the Summary Compensation Table of each Immunic proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ImmunicPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -38%
  2. Immunic Australia Pty Ltd.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?